Avita Medical Inc (Avita Medical) is a commercial-stage regenerative medical device company. The company develops products to meet the unmet medical needs of patients in conditions such as burns and chronic wounds, besides aesthetics and skin defects. Its lead product is RECELL System, a single-use (disposable) stand-alone, battery-operated device, which is approved for the treatment of acute thermal burns in adult patients, and also for treating vitiligo and full-thickness skin defects in the US. The company's proprietary application technology provides treatment harnessing the regenerative properties of the skin of patients. The company has operations in the US, Australia, Japan, and the UK, besides the European Union. Avita Medical is headquartered in Valencia, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Report Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Avita Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Avita Medical Inc Company Overview
- Avita Medical Inc Company Snapshot
- Avita Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Avita Medical Inc - Pipeline Analysis Overview
- Business Description
- Avita Medical Inc - Key Facts
- Avita Medical Inc - Major Products and Services
- Avita Medical Inc Pipeline Products by Development Stage
- Avita Medical Inc Pipeline Products Overview
- ReCell - Epidermolysis Bullosa
- ReCell - Epidermolysis Bullosa Product Overview
- ReCell - Hutchinson-Gilford Progeria Syndrome
- ReCell - Hutchinson-Gilford Progeria Syndrome Product Overview
- ReCell - Skin Rejuvenation
- ReCell - Skin Rejuvenation Product Overview
- ReCell - Vitiligo
- ReCell - Vitiligo Product Overview
- ReCell Go - Thermal Burns Full Thickness
- ReCell Go - Thermal Burns Full Thickness Product Overview
- ReCell Go - Thermal Burns Partial Thickness
- ReCell Go - Thermal Burns Partial Thickness Product Overview
- ReCell Go Mini
- ReCell Go Mini Product Overview
- Avita Medical Inc - Key Competitors
- Avita Medical Inc - Key Employees
- Avita Medical Inc - Key Employee Biographies
- Avita Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Avita Medical Inc, Recent Developments
- Apr 29, 2026: Avita Medical Announces TGA Certification in Australia and Medsafe Wand Listing in New Zealand for RECELL GO
- Apr 08, 2026: AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
- Apr 08, 2026: AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
- Apr 07, 2026: AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
- Jan 25, 2026: Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- Jan 25, 2026: Data at 2026 Boswick Burn & Wound Symposium Highlight First Integrated Use of AVITA Medical Technologies
- Nov 03, 2025: Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL System as a Standard of Care in Acute Wound Treatment
- Oct 28, 2025: AVITA Medical Welcomes Support for RECELL in Burns in Australia
- Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds
- Oct 01, 2025: CMS New Technology Add-on Payment Expands Access to RECELL for Patients With Non-Burn Acute Wounds
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Avita Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Avita Medical Inc Pipeline Products by Equipment Type
- Avita Medical Inc Pipeline Products by Indication
- Avita Medical Inc, Key Facts
- Avita Medical Inc, Major Products and Services
- Avita Medical Inc Number of Pipeline Products by Development Stage
- Avita Medical Inc Pipeline Products Summary by Development Stage
- ReCell - Epidermolysis Bullosa - Product Status
- ReCell - Epidermolysis Bullosa - Product Description
- ReCell - Hutchinson-Gilford Progeria Syndrome - Product Status
- ReCell - Hutchinson-Gilford Progeria Syndrome - Product Description
- ReCell - Skin Rejuvenation - Product Status
- ReCell - Skin Rejuvenation - Product Description
- ReCell - Vitiligo - Product Status
- ReCell - Vitiligo - Product Description
- ReCell Go - Thermal Burns Full Thickness - Product Status
- ReCell Go - Thermal Burns Full Thickness - Product Description
- ReCell Go - Thermal Burns Partial Thickness - Product Status
- ReCell Go - Thermal Burns Partial Thickness - Product Description
- ReCell Go Mini - Product Status
- ReCell Go Mini - Product Description
- Avita Medical Inc, Key Employees
- Avita Medical Inc, Key Employee Biographies
- Avita Medical Inc, Subsidiaries
- Avita Medical Inc, Joint Venture
- Glossary
- Avita Medical Inc Pipeline Products by Equipment Type
- Avita Medical Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Molnlycke Health Care AB
- Johnson & Johnson
- Organogenesis Holdings Inc
- Smith & Nephew Plc
- Integra LifeSciences Holdings Corp
- Vericel Corp
- Coloplast Corp
